Table: begin end state 1 5 non-cytoplasmic 6 55 transmembrane 56 62 non-cytoplasmic 63 84 transmembrane 85 111 cytoplasmic 112 137 transmembrane 138 145 non-cytoplasmic 146 164 transmembrane 165 169 cytoplasmic 170 187 transmembrane 188 206 non-cytoplasmic 207 227 transmembrane 228 263 cytoplasmic 264 286 transmembrane 287 323 non-cytoplasmic 324 350 transmembrane 351 362 cytoplasmic 363 386 transmembrane 387 397 non-cytoplasmic 398 416 transmembrane 417 422 cytoplasmic 423 451 transmembrane 452 477 non-cytoplasmic 478 498 transmembrane 499 516 cytoplasmic
Input: >WP_092347632.1 NCBI__GCF_900107645.1:WP_092347632.1 MWDGMLSGMLTGISTTMIPMNIAMVLFGCFMGSLIGMLPGLGPITAVALMIPVTYGLDPS SGMVLLAGVYYGAIFGGSTSSILINAPGEAATVATALDGYPLARQGHPGKALAVAAYASF SGGTISVIMLMIFAPILASVATSFQSADYFALMILGLTAVSAFAGRGGVLKALLMVVLGL MLATVGTDQTSGVQRFTFGSLELLDGIEFLLLAMATFALTEALSIVLKRDESSDSLKPRT IGFKNLKVTKSEFKQIAPTIGRSSLLGFIIGVLPGAGATLGSFMAYGMERNLASPEEQKK FGKGSLRGLAAPEAGNNAASSGSFVPLLCLGIPGSGTTAVMLGALIAYGIEPGPRMLTAN PQVFWGLIMSMYLGNVFLLILNLPLIPYFARLLAVPRNFMVPMILFFSLMGVYLVTFNDF DILMMVIFCIAAMALRLMNFPMAPLLLGFILGGLMEDNLRRALLIYNDSFSFMWERPLTL GINLATLLILVFPMIRSFIARRKGGGKPGNEVVVEV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server